|
US5665379A
(en)
|
1990-09-28 |
1997-09-09 |
Pharmacia & Upjohn Aktiebolag |
Lipid particle forming matrix, preparation and use thereof
|
|
MY115155A
(en)
|
1993-09-09 |
2003-04-30 |
Upjohn Co |
Substituted oxazine and thiazine oxazolidinone antimicrobials.
|
|
IL111004A
(en)
|
1993-09-30 |
1998-06-15 |
American Home Prod |
Oral formulations of rapamycin
|
|
US5536729A
(en)
|
1993-09-30 |
1996-07-16 |
American Home Products Corporation |
Rapamycin formulations for oral administration
|
|
US5707648A
(en)
|
1993-11-17 |
1998-01-13 |
Lds Technologies, Inc. |
Transparent liquid for encapsulated drug delivery
|
|
US5759548A
(en)
|
1993-11-30 |
1998-06-02 |
Lxr Biotechnology Inc. |
Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
|
|
GB9405304D0
(en)
|
1994-03-16 |
1994-04-27 |
Scherer Ltd R P |
Delivery systems for hydrophobic drugs
|
|
US5538737A
(en)
|
1994-11-30 |
1996-07-23 |
Applied Analytical Industries, Inc. |
Oral compositions of H2 -antagonists
|
|
FR2736550B1
(fr)
|
1995-07-14 |
1998-07-24 |
Sandoz Sa |
Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule
|
|
AU6964096A
(en)
|
1995-09-15 |
1997-04-01 |
Pharmacia & Upjohn Company |
Aminoaryl oxazolidinone n-oxides
|
|
US6964946B1
(en)
|
1995-10-26 |
2005-11-15 |
Baker Norton Pharmaceuticals, Inc. |
Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
|
|
DK0929578T3
(da)
|
1996-02-09 |
2003-08-25 |
Abbott Lab Bermuda Ltd |
Humane antistoffer, der binder human TNFalfa
|
|
US5891469A
(en)
|
1997-04-02 |
1999-04-06 |
Pharmos Corporation |
Solid Coprecipitates for enhanced bioavailability of lipophilic substances
|
|
US20030220234A1
(en)
|
1998-11-02 |
2003-11-27 |
Selvaraj Naicker |
Deuterated cyclosporine analogs and their use as immunodulating agents
|
|
BE1011899A6
(fr)
|
1998-04-30 |
2000-02-01 |
Ucb Sa |
Compositions pharmaceutiques gelifiables utilisables.
|
|
TR200100149T2
(tr)
|
1998-07-06 |
2001-10-22 |
Bristol-Myers Squibb Company |
Dual anjiyotensin endotelin alıcı antagonistleri olarak bifenil-sülfonamitler
|
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
DE19913692A1
(de)
|
1999-03-25 |
2000-09-28 |
Basf Ag |
Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
|
|
DE19929361A1
(de)
|
1999-06-25 |
2001-01-04 |
Basf Ag |
Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
|
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
|
US20030236236A1
(en)
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
|
GB9918037D0
(en)
|
1999-07-30 |
1999-09-29 |
Biochemie Gmbh |
Organic compounds
|
|
CN1217936C
(zh)
|
1999-12-28 |
2005-09-07 |
卫材株式会社 |
含有磺酰胺的杂环化合物
|
|
US20060183776A9
(en)
|
2000-03-03 |
2006-08-17 |
Eisai Co., Ltd. |
Liquid dosage formulations of donepezil
|
|
AR031130A1
(es)
|
2000-09-20 |
2003-09-10 |
Abbott Lab |
N-acilsulfonamidas promotoras de la apoptosis
|
|
US6720338B2
(en)
|
2000-09-20 |
2004-04-13 |
Abbott Laboratories |
N-acylsulfonamide apoptosis promoters
|
|
US20020055631A1
(en)
|
2000-09-20 |
2002-05-09 |
Augeri David J. |
N-acylsulfonamide apoptosis promoters
|
|
US6995162B2
(en)
|
2001-01-12 |
2006-02-07 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
|
NZ526531A
(en)
|
2001-01-31 |
2005-02-25 |
Pfizer Prod Inc |
Ether derivatives useful as inhibitors of phosphodiesterase type IV (PDE4) isozymes
|
|
US6927009B2
(en)
|
2001-05-22 |
2005-08-09 |
Fuji Photo Film Co., Ltd. |
Positive photosensitive composition
|
|
AU2002259204B2
(en)
|
2001-06-06 |
2008-01-17 |
Eli Lilly And Company |
Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
|
|
GB0123400D0
(en)
|
2001-09-28 |
2001-11-21 |
Novartis Ag |
Organic compounds
|
|
JP4598399B2
(ja)
|
2002-02-04 |
2010-12-15 |
エラン ファーマ インターナショナル，リミティド |
表面安定剤としてリゾチームを有するナノ粒子組成物
|
|
DK1480679T3
(da)
|
2002-02-26 |
2007-09-03 |
Astrazeneca Ab |
Farmaceutisk formulering af iressa, der omfatter et vandoplöseligt cellulosederivat
|
|
KR20040086452A
(ko)
|
2002-02-26 |
2004-10-08 |
아스트라제네카 아베 |
항암 화합물 ｚｄ1839의 신규한 결정질 형태
|
|
FR2836914B1
(fr)
|
2002-03-11 |
2008-03-14 |
Aventis Pharma Sa |
Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
|
TWI262077B
(en)
|
2002-04-29 |
2006-09-21 |
Merck & Co Inc |
Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
|
|
US20060177430A1
(en)
|
2002-12-20 |
2006-08-10 |
Chakshu Research Inc |
Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
|
|
US20050048112A1
(en)
|
2003-08-28 |
2005-03-03 |
Jorg Breitenbach |
Solid pharmaceutical dosage form
|
|
US8025899B2
(en)
|
2003-08-28 |
2011-09-27 |
Abbott Laboratories |
Solid pharmaceutical dosage form
|
|
US8377952B2
(en)
|
2003-08-28 |
2013-02-19 |
Abbott Laboratories |
Solid pharmaceutical dosage formulation
|
|
JP4336678B2
(ja)
|
2003-09-04 |
2009-09-30 |
株式会社日立超エル・エス・アイ・システムズ |
半導体装置
|
|
US7767684B2
(en)
|
2003-11-13 |
2010-08-03 |
Abbott Laboratories |
Apoptosis promoters
|
|
US7973161B2
(en)
|
2003-11-13 |
2011-07-05 |
Abbott Laboratories |
Apoptosis promoters
|
|
WO2005049593A2
(en)
|
2003-11-13 |
2005-06-02 |
Abbott Laboratories |
N-acylsulfonamide apoptosis promoters
|
|
US8614318B2
(en)
|
2003-11-13 |
2013-12-24 |
Abbvie Inc. |
Apoptosis promoters
|
|
US7642260B2
(en)
|
2003-11-13 |
2010-01-05 |
Abbott Laboratories, Inc. |
Apoptosis promoters
|
|
US7790190B2
(en)
|
2004-03-20 |
2010-09-07 |
Yasoo Health, Inc. |
Aqueous emulsions of lipophile solubilized with vitamin E TPGS and linoleic acid
|
|
DE602004009344T2
(de)
|
2004-04-19 |
2008-07-10 |
Symed Labs Ltd., Hyderabad |
Neues verfahren zur herstellung von linezolid und verwandten verbindungen
|
|
US7318503B2
(en)
|
2004-04-26 |
2008-01-15 |
Akebono Corporation (North America) |
Pad retaining clips
|
|
WO2005105039A1
(en)
|
2004-05-04 |
2005-11-10 |
Boehringer Ingelheim International Gmbh |
Solid pharmaceutical form comprising an ltb4 antagonist
|
|
WO2006008754A1
(en)
|
2004-07-20 |
2006-01-26 |
Symed Labs Limited |
Novel intermediates for linezolid and related compounds
|
|
MY191349A
(en)
|
2004-08-27 |
2022-06-17 |
Bayer Pharmaceuticals Corp |
New pharmaceutical compositions for the treatment of hyper-proliferative disorders
|
|
ATE395905T1
(de)
|
2004-08-27 |
2008-06-15 |
Bayer Pharmaceuticals Corp |
Pharmazeutische zusammensetzungen in form fester dispersionen zur behandlung von krebs
|
|
FR2875409B1
(fr)
|
2004-09-17 |
2010-05-07 |
Sanofi Aventis |
Composition pharmaceutique comprenant une dispersion solide a matrice polymere comprenant une phase continue de polydextrose et une phase continue d'un polymere autre que du polydextrose
|
|
EP1804823A4
(en)
|
2004-09-29 |
2010-06-09 |
Amr Technology Inc |
NEW CYCLOSPORIN ANALOGUE AND ITS PHARMACEUTICAL APPLICATIONS
|
|
US8624027B2
(en)
|
2005-05-12 |
2014-01-07 |
Abbvie Inc. |
Combination therapy for treating cancer and diagnostic assays for use therein
|
|
DK1888550T3
(da)
|
2005-05-12 |
2014-09-29 |
Abbvie Bahamas Ltd |
Apoptosepromotorer
|
|
CA2608333A1
(en)
|
2005-05-16 |
2006-11-23 |
Irm Llc |
Pyrrolopyridine derivatives as protein kinase inhibitors
|
|
CN1706371B
(zh)
|
2005-05-27 |
2010-11-10 |
沈阳药科大学 |
一种高效的马蔺子素制剂及其制备方法
|
|
TW200716636A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Heterocyclic spiro-compounds
|
|
NZ565255A
(en)
|
2005-06-22 |
2010-04-30 |
Plexxikon Inc |
Pyrrolo[2,3-b] pyridine derivatives as protein kinase inhibitors
|
|
US7514068B2
(en)
|
2005-09-14 |
2009-04-07 |
Concert Pharmaceuticals Inc. |
Biphenyl-pyrazolecarboxamide compounds
|
|
WO2007043057A2
(en)
|
2005-10-11 |
2007-04-19 |
Yissum, Research Development Company Of The Hebrew University Of Jerusalem |
Compositions for nasal delivery
|
|
EP1959926A1
(en)
|
2005-10-25 |
2008-08-27 |
Abbott Laboratories |
Formulation comprising a drug of low water solubility and method of use thereof
|
|
US7151188B1
(en)
|
2005-11-16 |
2006-12-19 |
General Electric Company |
Process for the production of mercaptoalkylalkoxysilanes
|
|
JP2009537535A
(ja)
|
2006-05-15 |
2009-10-29 |
エンサイシブ・ファーマシューティカルズ・インコーポレイテッド |
エンドセリンアンタゴニストの投与を含む睡眠時無呼吸を治療するための方法および組成物
|
|
EP2037919A2
(en)
|
2006-06-30 |
2009-03-25 |
Schering Corporation |
Method of using substituted piperidines that increase p53 activity
|
|
ES2360741T3
(es)
|
2006-07-14 |
2011-06-08 |
Chemocentryx, Inc. |
Triazolil fenil bencenosulfonamidas.
|
|
EP1880715A1
(en)
|
2006-07-19 |
2008-01-23 |
Abbott GmbH & Co. KG |
Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same
|
|
US7799790B2
(en)
|
2006-07-20 |
2010-09-21 |
Helm Ag |
Amorphous aripiprazole and process for the preparation thereof
|
|
RU2454220C2
(ru)
|
2006-08-16 |
2012-06-27 |
Новартис Аг |
Способ получения твердых дисперсий высококристаллических терапевтических соединений
|
|
US7842681B2
(en)
|
2006-09-05 |
2010-11-30 |
Abbott Laboratories |
Treatment of myeoproliferative diseases
|
|
US8796267B2
(en)
|
2006-10-23 |
2014-08-05 |
Concert Pharmaceuticals, Inc. |
Oxazolidinone derivatives and methods of use
|
|
AU2007316558A1
(en)
|
2006-11-09 |
2008-05-15 |
Abbott Gmbh & Co. Kg |
Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
|
|
EP2112925A4
(en)
*
|
2006-11-15 |
2013-01-09 |
Abbott Lab |
SOLID PHARMACEUTICAL DOSAGE FORMULATIONS
|
|
US20080182845A1
(en)
|
2006-11-16 |
2008-07-31 |
Abbott Laboratories |
Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection
|
|
JP5130305B2
(ja)
|
2007-02-15 |
2013-01-30 |
エフ．ホフマン−ラ ロシュ アーゲー |
Ｔａａｒ１リガンドとしての２−アミノオキサゾリン
|
|
RU2351352C2
(ru)
|
2007-04-09 |
2009-04-10 |
Закрытое акционерное общество "Санкт-Петербургский институт фармации" |
Твердая нанокомпозиция для доставки биологически активных веществ
|
|
WO2008124878A1
(en)
|
2007-04-13 |
2008-10-23 |
Cryptopharma Pty Ltd |
Non-steroidal compounds
|
|
WO2008131259A1
(en)
|
2007-04-19 |
2008-10-30 |
Concert Pharmaceuticals Inc. |
Deuterated morpholinyl compounds
|
|
US7531685B2
(en)
|
2007-06-01 |
2009-05-12 |
Protia, Llc |
Deuterium-enriched oxybutynin
|
|
US20090131485A1
(en)
|
2007-09-10 |
2009-05-21 |
Concert Pharmaceuticals, Inc. |
Deuterated pirfenidone
|
|
US20090118238A1
(en)
|
2007-09-17 |
2009-05-07 |
Protia, Llc |
Deuterium-enriched alendronate
|
|
US20090088416A1
(en)
|
2007-09-26 |
2009-04-02 |
Protia, Llc |
Deuterium-enriched lapaquistat
|
|
US20090082471A1
(en)
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched fingolimod
|
|
JP2010540634A
(ja)
|
2007-10-01 |
2010-12-24 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
シクロホスファミドを用いて自己免疫神経疾患を処置する方法
|
|
WO2009045476A1
(en)
|
2007-10-02 |
2009-04-09 |
Concert Pharmaceuticals, Inc. |
Pyrimidinedione derivatives
|
|
JP2011500569A
(ja)
|
2007-10-12 |
2011-01-06 |
マサチューセッツ インスティテュート オブ テクノロジー |
ワクチンナノテクノロジー
|
|
US8410124B2
(en)
|
2007-10-18 |
2013-04-02 |
Concert Pharmaceuticals Inc. |
Deuterated etravirine
|
|
US20090105338A1
(en)
|
2007-10-18 |
2009-04-23 |
Protia, Llc |
Deuterium-enriched gabexate mesylate
|
|
CA2703591C
(en)
|
2007-10-26 |
2013-05-07 |
Concert Pharmaceuticals, Inc. |
Deuterated darunavir
|
|
WO2009064938A1
(en)
|
2007-11-16 |
2009-05-22 |
Abbott Laboratories |
Method of treating arthritis
|
|
JP2011506338A
(ja)
|
2007-12-06 |
2011-03-03 |
アボット・ラボラトリーズ |
癌の治療のためのａｂｔ−２６３の経口用組成物
|
|
BRPI0906490A2
(pt)
|
2008-01-15 |
2015-07-14 |
Abbott Lab |
Vetores de expressão de mamífero melhorados e uso dos mesmos
|
|
CN101220008B
(zh)
|
2008-01-21 |
2011-04-27 |
中国科学院广州生物医药与健康研究院 |
化合物abt-263的合成方法
|
|
US20090203709A1
(en)
|
2008-02-07 |
2009-08-13 |
Abbott Laboratories |
Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor
|
|
CN101548960B
(zh)
|
2008-04-01 |
2012-11-07 |
沈阳药科大学 |
高溶出度口服联苯双酯胶囊及其制备方法
|
|
US8168784B2
(en)
|
2008-06-20 |
2012-05-01 |
Abbott Laboratories |
Processes to make apoptosis promoters
|
|
CN102238945B
(zh)
|
2008-10-07 |
2014-10-29 |
阿斯利康(英国)有限公司 |
药物制剂514
|
|
US8557983B2
(en)
|
2008-12-04 |
2013-10-15 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
UA108193C2
(uk)
*
|
2008-12-04 |
2015-04-10 |
|
Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань
|
|
US20100160322A1
(en)
*
|
2008-12-04 |
2010-06-24 |
Abbott Laboratories |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
US8563735B2
(en)
|
2008-12-05 |
2013-10-22 |
Abbvie Inc. |
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
|
|
US8586754B2
(en)
|
2008-12-05 |
2013-11-19 |
Abbvie Inc. |
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
|
|
CN106008322B
(zh)
*
|
2008-12-05 |
2018-09-04 |
Abbvie 公司 |
作为用于治疗癌症和免疫疾病的bcl-2-选择性诱发细胞凋亡药剂的磺酰胺衍生物
|
|
WO2010077740A2
(en)
|
2008-12-09 |
2010-07-08 |
Cytokine Pharmasciences, Inc. |
Novel antiviral compounds, compositions, and methods of use
|
|
US8959548B2
(en)
*
|
2008-12-22 |
2015-02-17 |
Verizon Patent And Licensing Inc. |
Presenting advertisements with video program descriptions
|
|
US20120094963A1
(en)
|
2008-12-23 |
2012-04-19 |
of Queen Elizabeth near Dublin |
Targeting prodrugs and compositions for the treatment of gastrointestinal diseases
|
|
BRPI1006116A2
(pt)
*
|
2009-01-19 |
2018-03-13 |
Abbott Lab |
"agentes indutores da apoptose para o tratamento de câncer e doenças imunes e autoimunes".
|
|
BRPI1006115A8
(pt)
|
2009-01-19 |
2017-09-26 |
Abbott Lab |
"agentes indutores de apoptose para o tratamento de câncer e doenças autoimunes".
|
|
US8362013B2
(en)
|
2009-04-30 |
2013-01-29 |
Abbvie Inc. |
Salt of ABT-263 and solid-state forms thereof
|
|
US20100280031A1
(en)
|
2009-04-30 |
2010-11-04 |
Paul David |
Lipid formulation of apoptosis promoter
|
|
US8728516B2
(en)
|
2009-04-30 |
2014-05-20 |
Abbvie Inc. |
Stabilized lipid formulation of apoptosis promoter
|
|
US20100278921A1
(en)
|
2009-04-30 |
2010-11-04 |
Fischer Cristina M |
Solid oral formulation of abt-263
|
|
US20100297194A1
(en)
|
2009-04-30 |
2010-11-25 |
Nathaniel Catron |
Formulation for oral administration of apoptosis promoter
|
|
CN102448959B
(zh)
*
|
2009-05-26 |
2015-06-17 |
艾伯维巴哈马有限公司 |
用于治疗癌症和免疫和自身免疫疾病的细胞程序死亡诱导药剂
|
|
US8546399B2
(en)
|
2009-05-26 |
2013-10-01 |
Abbvie Inc. |
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
TWI532484B
(zh)
|
2009-06-08 |
2016-05-11 |
艾伯維有限公司 |
包含凋亡促進劑之固態分散劑
|
|
TWI540132B
(zh)
|
2009-06-08 |
2016-07-01 |
亞培公司 |
Ｂｃｌ-２族群抑制劑之口服醫藥劑型
|
|
US8691938B2
(en)
|
2009-06-11 |
2014-04-08 |
Abbvie Inc. |
Anti-viral compounds
|
|
JP2012530704A
(ja)
|
2009-06-18 |
2012-12-06 |
アボット・ラボラトリーズ |
安定なナノ粒子状薬物懸濁液
|
|
BR112012006252A2
(pt)
|
2009-09-20 |
2017-05-23 |
Abbott Lab |
"formas cristalinas de abt-263 e solvatos para o uso no tratamento de doenças relacionadas á proteína bcl-2".
|
|
CN101798292A
(zh)
|
2010-03-29 |
2010-08-11 |
无锡好芳德药业有限公司 |
ABT-263衍生的新型Bcl-2蛋白抑制剂的制备
|
|
TWI520960B
(zh)
|
2010-05-26 |
2016-02-11 |
艾伯維有限公司 |
用於治療癌症及免疫及自體免疫疾病之細胞凋亡誘導劑
|
|
UA113500C2
(xx)
|
2010-10-29 |
2017-02-10 |
|
Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб
|
|
MX349533B
(es)
|
2010-10-29 |
2017-08-02 |
Abbvie Inc |
Dispersiones solidas que contienen un agente inductor de apoptosis.
|
|
AR083946A1
(es)
|
2010-11-23 |
2013-04-10 |
Abbott Lab |
Metodos de tratamiento con inhibidores selectivos de bcl-2
|
|
RU2628560C2
(ru)
|
2010-11-23 |
2017-08-18 |
Эббви Инк. |
Соли и кристаллические формы индуцирующего апоптоз агента
|
|
JP6095678B2
(ja)
|
2011-11-11 |
2017-03-15 |
エスアイオーツー・メディカル・プロダクツ・インコーポレイテッド |
薬剤パッケージ用の不動態化、ｐＨ保護又は滑性皮膜、被覆プロセス及び装置
|